David Hoff, PharmD
The publication of the Beers List in 1991 was a seminal event in the prevention of adverse drug events in older adults. Now, younger patients stand to benefit from a similarly ground-breaking effort in pediatrics.
The KIDs (Key Potentially Inappropriate Drugs in Pediatrics) List, published this spring in the Journal of Pediatric Pharmacology and Therapeutics (2020;25[3]:175-191), contains 67 drugs and 10 excipients that are potentially inappropriate for